N-acetylcysteine as a potential adjuvant to antivenom for viper envenomation: a proof-of-concept mechanistic pilot study
N-acetylcysteine as a potential adjuvant to antivenom for viper envenomation: a proof-of-concept mechanistic pilot study
N-acetylcysteine as a potential adjuvant to antivenom for viper envenomation: a proof-of-concept mechanistic pilot study Abstract Background Oxidative stress has a significant role in the pathophysiology of snake envenomation. Despite that, antivenom, the mainstay treatment, does not protect against envenomation-induced oxidative stress. This therapeutic gap highlights the need for adjunctive therapy targeting oxidative stress. The current study aimed to determine the role of oxidative stress in the pathophysiology of viper snake envenomation and assess the role of N-acetylcysteine (NAC) as a co-adjuvant therapy in mitigating toxicity. A clinical pilot study was conducted on 30 Egyptian patients admitted to Alexandria Poison Centre within 24 h after bite by viperid snakes. The patients were categorized into two groups: Antivenom (ASV) group and Antivenom plus N-acetylcysteine (ASV + NAC) group. Oxidative stress biomarkers and severity grading were assessed on admission and after ...
- Get link
- X
- Other Apps
.jpg)